🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00510M104
- Market Cap
- Micro Cap
- IPO
- 6/25/2021 · $6.00/share
Business: Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections. The Company's approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D pipeline includes early stage antibiotic candidates that target other Gram-positive bacteria.
Company Contact
- CEO
- David P. Luci
- VPF
- Robert G. Shawah
- Headquarters
- 259 Liberty Avenue, Staten Island, NY 10305
- Phone
- 917-533-1469
- Investor Relations
- David P. Luci · 917-533-1469 · davidluci@acurxpharma.com